ARS Pharmaceuticals Inc (NASDAQ: SPRY) flaunted slowness of -15.23% at $14.08, before settling in for the price of $16.61 at the close. Taking a more long-term approach, SPRY posted a 52-week range of $3.76-$18.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -34.76%. Meanwhile, its Annual Earning per share during the time was -1.44%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.96%. This publicly-traded company’s shares outstanding now amounts to $96.41 million, simultaneously with a float of $49.21 million. The organization now has a market capitalization sitting at $1.36 billion. At the time of writing, stock’s 50-day Moving Average stood at $14.53, while the 200-day Moving Average is $10.71.
ARS Pharmaceuticals Inc (SPRY) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the ARS Pharmaceuticals Inc industry. ARS Pharmaceuticals Inc’s current insider ownership accounts for 49.24%, in contrast to 40.44% institutional ownership. According to the most recent insider trade that took place on Nov 11 ’24, this organization’s 10% Owner sold 528,456 shares at the rate of 18.04, making the entire transaction reach 9,534,642 in total value, affecting insider ownership by 5,274,735. Preceding that transaction, on Nov 12 ’24, Company’s 10% Owner sold 34,814 for 17.49, making the whole transaction’s value amount to 609,064. This particular insider is now the holder of 5,257,328 in total.
ARS Pharmaceuticals Inc (SPRY) Earnings and Revenue Records
ARS Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 10.96% and is forecasted to reach -0.82 in the upcoming year.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Trading Performance Indicators
Let’s observe the current performance indicators for ARS Pharmaceuticals Inc (SPRY). It’s Quick Ratio in the last reported quarter now stands at 32.78. The Stock has managed to achieve an average true range (ATR) of 1.16. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2729.88.
In the same vein, SPRY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.47, a figure that is expected to reach -0.13 in the next quarter, and analysts are predicting that it will be -0.82 at the market close of one year from today.
Technical Analysis of ARS Pharmaceuticals Inc (SPRY)
Now, what If we examine the latest scores posted by [ARS Pharmaceuticals Inc, SPRY]. During the last 5-days, its volume was better the volume of 0.8 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 46.61% While, its Average True Range was 1.30.
Raw Stochastic average of ARS Pharmaceuticals Inc (SPRY) in the period of the previous 100 days is set at 59.58%, which indicates a major rise in contrast to 6.04% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 87.44% that was higher than 73.96% volatility it exhibited in the past 100-days period.
